BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 111003
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.111003
Prediction model for the occurrence of acute pancreatitis after endoscopic retrograde cholangiopancreatography based on multidimensional indicators
Xun-Xun Cao, Min Sun
Xun-Xun Cao, Min Sun, Department of Gastroenterology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China
Author contributions: Cao XX conceived the project, acquired and analyzed data, and wrote the manuscript; Sun M designed the study and edited and critically revised the manuscript; and all authors contributed to the article and approved the submitted version.
Institutional review board statement: This study was reviewed and approved by the Institutional Review Board of the Affiliated Hospital of Xuzhou Medical University, No. XYFY2023-KL375-01.
Informed consent statement: Due to the retrospective nature of the study, the Ethics Committee approved the waiver of informed consent.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The original anonymous dataset is available upon request from the corresponding author.
Corresponding author: Min Sun, Associate Professor, Department of Gastroenterology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. sunminnt820919@163.com
Received: June 24, 2025
Revised: July 28, 2025
Accepted: October 20, 2025
Published online: December 27, 2025
Processing time: 184 Days and 1.4 Hours
Core Tip

Core Tip: A predictive model of acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) was constructed based on age, total cholesterol, history of pancreatitis, pancreatic ductography, and bleeding. Its application in clinical settings allows for targeted and prophylactic treatments for different patients and reduces the risk of PEP in patients.